Technology & Quality


SaudiVax accumulated technologies for entire value chain of biopharmaceutical industry through recombination and bioreactors (Xcellerex) technology

  • Recombinant Vaccines:

SaudiVax manufacturing recombinant vaccines that are a vaccine produced through recombinant DNA technology. This involves inserting the DNA encoding an antigen (such as a bacterial surface protein) that stimulates an immune response into bacterial or mammalian cells, expressing the antigen in these cells and then purifying it from them.

  • Xcellerex Bioreactors & Fermentors

GE xcellerex portfolio of single use, stirred tank bioreactors and fermenters is a modular, turnkey platform for process development through to manufacturing scale.